DJO Global ARTROMOT-SP3 Mode D'emploi page 22

Contents
Device Description ARTROMOT®-SP
Figures ARTROMOT®-SP
Symbol overview ARTROMOT®-SP
. How to use the CPM device
. Fields of application
. Therapy objectives
. Indications
. Contraindications
. Description of the ARTROMOT®-SP
. Description of the device components
. Description of the programming unit
. Explanation of symbols
. Explanation of symbols (connections and nameplate)
. Safety information
. Device setup
. Connecting the device, performance check
. Adjusting the device to the patient
. Setting the treatment values
. General information on programming ARTROMOT®-SP
. Programming ARTROMOT®-SP Standard
. Treatment value details – Standard models
. Programming ARTROMOT®-SP Comfort
. Protocol details – Comfort models
. Care, Maintenance, Transport, Conversion
. Care
. Maintenance (fuse replacement)
. . Transport
. . Conversion
. Environmental Protection Statement
. Specifications
. IEC : and IEC :
. Electromagnetic emissions
. Electromagnetic immunity
. Recommended separation distances
. Contact
. Technical Service
. Technical hotline
. Shipment
. Spare parts
. Declaration of conformity
. How to use the CPM device
ΙΙΙ
. Fields of application
VΙΙΙ
V
ARTROMOT®-SP is a motor-operated
Continuous Passive Motion (CPM) device
41
providing motion to the ankle joint.
41
Suitable for use in hospitals, clinics,
41
general practices and rental services, it is
41
an important supplement to medical and
41 therapeutic treatment.
42
. Therapy objectives
43
46
CPM therapy with ARTROMOT®-SP is
47
mainly used to prevent the negative e ects
48
of immobilization, to allow patients to
51
regain painless mobility of joints at an early
51 stage and to promote healing and achieve
a positive functional result.
52
54
54
Other objectives of therapy include:
55
– improvement of joint metabolism
56
– prevention of joint sti ness
60
– promotion of the regeneration and heal-
61
ing of cartilage and damaged ligaments
65
– faster hematoma/fluid resorption
65
– improved lymph and blood circulation
65
– thrombosis and embolism prophylaxis
67
68
69
69
71
72
74
75
76
76
76
76
77
. Indications
The CPM device is indicated in the treat-
ment of most injuries and diseases of the
ankle joint as well as in the postoperative
treatment after joint surgery and in the
treatment of joint diseases. Examples:
– joint distortion and contusion
– arthrotomy and arthroscopy procedures
in combination with synovectomy,
arthrolysis or other intra-articular
interventions
– mobilization of joints in anesthetized
patients
– exercise-stable fractures after surgery,
pseudoarthrosis and osteotomy
– myoplasty
– arthroplasties including implantation of
endoprostheses
. Contraindications
Do NOT use ARTROMOT®-SP on
patients with:
– acute inflammatory processes in the
joints, unless on the order of a physician
– spastic paralysis
– unstable osteosynthesis